e-learning
resources
Glasgow 2004
Monday 06.09.2004
Longitudinal studies and determinants of lung function and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
When is FEV
1
loss excessive? – an investigation of the relationship between year-to-year and long-term spirometry changes
M. L. Wang, B. Avashia, E. L. Petsonk (Morgantown, Institute, United States Of America)
Source:
Annual Congress 2004 - Longitudinal studies and determinants of lung function and COPD
Session:
Longitudinal studies and determinants of lung function and COPD
Session type:
Oral Presentation
Number:
2687
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. L. Wang, B. Avashia, E. L. Petsonk (Morgantown, Institute, United States Of America). When is FEV
1
loss excessive? – an investigation of the relationship between year-to-year and long-term spirometry changes. Eur Respir J 2004; 24: Suppl. 48, 2687
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Duration and frequency of spirometry needed to accurately reflect longitudinal change of FEV1 in COPD
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Year: 2021
Re-assessing the importance of FEV
1
decline
Source: Eur Respir Monogr 2015; 69: 134-142
Year: 2015
Exploring the clinical utility of measuring reversibility in mid expiratory flow and its relationship with FEV1 reversibility in patients with asthma.
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
The relationship between long-term correlations (self-similarity) in PEF and FEV1 in COPD
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012
The evaluation of different factors that cause FEV1 decline in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 135s
Year: 2001
Individual decline of FEV1 show diversity in COPD
Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases
Year: 2012
The correlation of annual rate of FEV
1
decline with the temperature of expired air in COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
The variable relationship between changes in lung density and FEV1 in smokers
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017
Is FEV
1
better than PEF at detecting asthmatic changes in diurnal variation?
Source: Annual Congress 2011 - The work environment in the clinic
Year: 2011
Regular follow-up in severe asthma may reduce the rate of exacerbations and the FEV1 decline
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Early health status improvements decline after LVRS despite persistent reduction in lung volume
Source: Eur Respir J 2002; 20: Suppl. 38, 607s
Year: 2002
Correlation of airway obstruction and patient-reported endpoints in clinical studies
Source: Eur Respir J 2001; 17: 220-224
Year: 2001
Changes in forced oscillatory parameters in reversibility testing as predictors for cough variant asthma
Source: International Congress 2018 – Asthma management
Year: 2018
Long-term change in reactance by forced oscillation technique correlates with FEV1decline in moderate COPD patients
Source: Eur Respir J , 49 (4) 1601534; DOI: 10.1183/13993003.01534-2016
Year: 2017
A one-week period of home spirometry provides a reliable reflection of PEF and FEV1 variation in children with and without asthma
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007
FEV1 decline in occupational asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 488s
Year: 2003
3-years‘ follow-up of spirometric changes in asthmatic patients with and without irreversible airflow limitation
Source: Eur Respir J 2005; 26: Suppl. 49, 507s
Year: 2005
Volume changes after segmental vapor ablation and associated improvements in FEV1
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
How often FEV
1
underestimates bronchodilator response?
Source: Eur Respir J 2003; 22: Suppl. 45, 100s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept